[Economic evaluation of the treatments of non-metastatic prostate cancer]

Abstract

Objectives: Prostate cancer is the most frequent cancer and the third leading cause of cancer death in men in France. The development of treatment for prostate cancer is fast and sometimes relies on costly innovations. Medico-economic studies are however rare in this area. This literature review aims to summarize available medico-economic data on the initial management of localized prostate cancer and discuss the quality and usability of existing economic studies on the subject.

Materials and method: Literature review was done using PubMed and Cochrane databases. Studies and articles were selected based on several criteria: population with initial treatment for localized prostate cancer (without metastasis), comparative studies with surgery as control treatment, studies in countries members of the OECD, articles in English or French published between 2004 and 2014.

Results: The surgical robot, one of the newest innovations, is more expensive than conventional open surgery or no robotic laparoscopy, even if it is associated with a reduction of the original period of stay. Radiation therapy seems more expensive than surgery as initial therapy of localized prostate cancer.

Conclusion: Conclusions remain limited because of the rarity of reliable health economic studies on the subject.

Keywords: Aspects médico-économiques; Cancer de la prostate; Costs; Coûts; Medico-economic aspects; Prostate cancer; Prostatectomie totale; Public health; Radiothérapie; Santé publique.